The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats

D C McVey1, S R Vigna

  • 1Department of Cell Biology, Box 3709, Duke University Medical Center and Durham V. A. Medical Center, Durham, North Carolina 27710, USA.

Peptides
|August 22, 2001
PubMed

Insights

Clostridium difficile toxin A triggers substance P release and gut inflammation via vanilloid receptor subtype 1 (VR1) activation. Blocking VR1 with capsazepine inhibits this inflammatory response in rats.

Area of Science:

  • Gastroenterology
  • Neuroscience
  • Immunology

Background:

  • Clostridium difficile toxin A is a major cause of antibiotic-associated diarrhea and intestinal inflammation.
  • The precise mechanism of toxin A-induced inflammation, particularly the role of substance P (SP) and sensory neurons, remains unclear.

Purpose of the Study:

  • To investigate the role of the vanilloid receptor subtype 1 (VR1) in mediating toxin A-induced substance P release and intestinal inflammation in a rat model.

Main Methods:

  • Rats were pretreated with capsazepine, a VR1 antagonist, or vehicle before administration of Clostridium difficile toxin A.
  • Intraluminal administration of capsaicin, a VR1 agonist, was used to mimic toxin A effects.
  • Substance P levels and inflammatory markers in the rat ileum were assessed.

Main Results:

  • Capsazepine pretreatment significantly inhibited toxin A-induced SP release and intestinal inflammation.
  • Intraluminal capsaicin administration induced inflammation comparable to toxin A.
  • Capsazepine also inhibited capsaicin-induced intestinal inflammation.

Conclusions:

  • Clostridium difficile toxin A stimulates SP release from primary sensory neurons through the activation of VR1 receptors.
  • VR1 receptor activation is a key pathway in toxin A-induced intestinal inflammation.
  • Targeting VR1 receptors may offer a therapeutic strategy for Clostridium difficile-associated intestinal inflammation.